Oct 17, 2019 8:00am EDT NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL™ Enabled Therapies
Oct 11, 2019 8:00am EDT NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board
Sep 26, 2019 9:08am EDT NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
Sep 09, 2019 8:39am EDT NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th
Aug 14, 2019 4:05pm EDT NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019
Jul 30, 2019 8:00am EDT NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board